Skip to content
★ Sign in to follow
MK

Martin Kristofferson

Board Director
Autre membre du conseil
EQL Pharma AB
Insider activity · 24 months2 buys0 salesCumulative net flow
Total declarations
11
Company
1
▲ Purchases (8 ops.)
€313k
▼ Sales (0 ops.)
—

Latest filing published 23 Dec 2025 for EQL Pharma AB, €92k.

Filing timeline

BuySale
Martin Kristofferson

Insider track record

Disclosed buys
8
Disclosed sells
0
Signal history

Closed purchases

Market purchases
8

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Martin Kristofferson: trading record in brief

Martin Kristofferson is a declared insider of EQL Pharma AB (board member), with filings sourced from Finansinspektionen. The record holds 11 filings, for trades running from 10 May 2021 to 23 December 2025.

On the market, this insider has only ever bought: 8 purchases, €313k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2025: 2 purchases and no sales on the market.

In size, the median ticket on the buying side is €15k. Clusters matter here: 1 out of 8 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

Most recently, on 23 December 2025, the filings show an open-market purchase worth €92k in EQL Pharma AB. Filings reach the Finansinspektionen feed a median of 1 day after the trade. The regulation allows three business days to notify a trade (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Martin Kristofferson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations11 total
  • ▲
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEQL Pharma AB
    1M SEK11FI-SE
    19,225 shares@ SEK 52.270.14% mcap39.7% of flowAktieISIN SE0005497732FI:A003V027-1
    Canonical exit: 23 Mar 2026 (T+90)
  • ▲
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEQL Pharma AB
    2M SEK25FI-SE
    23,300 shares@ SEK 66.520.21% mcap60.3% of flowAktieFI:A003S639-1
    Canonical exit: 24 Dec 2025 (T+90)
  • ▲
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEQL Pharma AB
    280,700 SEK8FI-SE
    5,000 shares@ SEK 56.147.1% of flowAktieISIN SE0005497732FI:csv-aa3078f4dad390480b66
    Canonical exit: 1 Jan 2025 (T+90)
  • ●
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEQL Pharma AB
    88,500 SEK0FI-SE
    50,000 shares@ SEK 1.772.1% of flowOptionISIN SE0005497732FI:csv-847796cc448eade19fb6
  • ●
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEQL Pharma AB
    193,200 SEK0FI-SE
    70,000 shares@ SEK 2.765.0% of flowTeckningsoptionFI:csv-40e4b02fa345d5f9f812
  • ●
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEQL Pharma AB
    102,580 SEK0FI-SE
    46,000 shares@ SEK 2.232.9% of flowTeckningsoptionFI:csv-e0d74eeb645d1f2b5f49
  • ▲
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEQL Pharma AB
    95,850 SEK7FI-SE
    2,700 shares@ SEK 35.502.7% of flowAktieISIN SE0005497732FI:csv-15b0652fc3d7a92f5f7c
    Canonical exit: 15 Nov 2021 (T+90)
  • ▲
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEQL Pharma AB
    104,288 SEK7FI-SE
    2,781 shares@ SEK 37.503.0% of flowAktieISIN SE0005497732FI:csv-7293e4931f96b721417e
    Canonical exit: 16 Aug 2021 (T+90)
  • ▲
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEQL Pharma AB
    84,322 SEK7FI-SE
    2,219 shares@ SEK 38.002.4% of flowAktieISIN SE0005497732FI:csv-7cdb2a2aa7560b1fc94b
    Canonical exit: 10 Aug 2021 (T+90)
  • ▲
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEQL Pharma AB
    190,000 SEK8FI-SE
    5,000 shares@ SEK 38.005.4% of flowAktieISIN SE0005497732FI:csv-531eec2803d0cd6e1beb
    Canonical exit: 8 Aug 2021 (T+90)
  • ▲
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEQL Pharma AB
    92,500 SEK7FI-SE
    2,500 shares@ SEK 37.002.6% of flowAktieISIN SE0005497732FI:csv-dfafb004251526c28b5b
    Canonical exit: 9 Aug 2021 (T+90)

11 of 11 declarations